SR9009 Product Specifications:

SR9009, often classified as a selective androgen receptor modulator (SARM), captivates researchers with its unique profile. Scientists design it as a synthetic small molecule, featuring a pyrrolidine core. Consequently, its structure ensures high specificity for nuclear receptors. Moreover, it exhibits notable oral bioavailability. Thus, it intrigues biochemical studies.

The compound binds tightly to Rev-ErbA receptors, showing strong affinity. Furthermore, it resists rapid metabolism in the body. As a result, scientists explore SR9009’s pharmacokinetic properties. Additionally, its synthesis relies on complex organic chemistry techniques. Hence, researchers investigate its production methods.

SR9009’s development in the 2010s by Scripps Research Institute marked a milestone. Initially, researchers crafted it for experimental purposes. Subsequently, its name reflects its developmental code. Moreover, it garners attention in global laboratories. Therefore, SR9009 fuels innovative research projects.

In experiments, SR9009 circulates effectively in biological systems. Furthermore, it maintains stability under physiological conditions. Consequently, scientists study its molecular interactions. Additionally, labs worldwide analyze its chemical traits. Thus, SR9009 drives advancements in receptor research, inspiring curiosity and deeper scientific exploration.

• Appearance:Capsule
• Chemical Formula:C20H24ClN3O4S
• PubChem CID:57394020
• CAS Number:1379686-30-2
• Molecular Weight:437.9 g/mol
• Synonyms:SR-9009, SR 9009